Cargando…
Therapeutic Options for Systemic Sclerosis: Current and Future Perspectives in Tackling Immune-Mediated Fibrosis
Systemic sclerosis (SSc) is a severe auto-immune, rheumatic disease, characterized by excessive fibrosis of the skin and visceral organs. SSc is accompanied by high morbidity and mortality rates, and unfortunately, few disease-modifying therapies are currently available. Inflammation, vasculopathy,...
Autores principales: | Papadimitriou, Theodoros-Ioannis, van Caam, Arjan, van der Kraan, Peter M., Thurlings, Rogier M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869277/ https://www.ncbi.nlm.nih.gov/pubmed/35203525 http://dx.doi.org/10.3390/biomedicines10020316 |
Ejemplares similares
-
Transcription Factors in Cartilage Homeostasis and Osteoarthritis
por: Neefjes, Margot, et al.
Publicado: (2020) -
TGFβ/BMP Signaling Pathway in Cartilage Homeostasis
por: Thielen, Nathalie G.M., et al.
Publicado: (2019) -
Unraveling SSc Pathophysiology; The Myofibroblast
por: van Caam, Arjan, et al.
Publicado: (2018) -
Current and future treatment options in SIADH
por: Zietse, Robert, et al.
Publicado: (2009) -
Treatment of toxoplasmosis: Current options and future perspectives
por: Konstantinovic, Neda, et al.
Publicado: (2019)